D2 dopaminergic receptors: normal and abnormal transduction mechanisms.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Hormone Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000182494PMID 1306522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PKC modulation of inhibitory coupling of angiotensin II receptors with adenylate cyclase in lactotroph cells.

  1992cited by this paper
• Effects of Dopaminergic Transmission Interruption on the D2 Receptor Isoforms in Various Cerebral Tissues

  1992cited by this paper
• Differential G protein-mediated coupling of D2 dopamine receptors to K+ and Ca2+ currents in rat anterior pituitary cells.

  1992cited by this paper
• G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors.

  1991cited by this paper
• Differential Mechanisms of Dopamine and Somatostatin Inhibition of Prolactin Secretion from Anterior Pituitary Cells

  1991cited by this paper
• Differential plasticity of the dopaminergic D2 receptor mRNA isoforms under haloperidol treatment, as evidenced by in situ hybridization in rat anterior pituitary.

  1991cited by this paper
• Differential coupling with pertussis toxin-sensitive G proteins of dopamine and somatostatin receptors involved in regulation of adenohypophyseal secretion.

  1990cited by this paper
• Dual mechanisms of inhibition by dopamine of basal and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells. Evidence for an inhibition not mediated by voltage-dependent Ca2+ channels.

  1990cited by this paper
• Estradiol modulates protein kinase C activity in the rat pituitary in vivo and in vitro.

  1990cited by this paper
• Dopamine inhibits the arachidonate and prolactin release stimulated by thyrotropin-releasing hormone through an islet-activating protein-sensitive GTP-binding protein in anterior pituitary cells.

  1990cited by this paper
• Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells.

  1990cited by this paper
• Receptor-effector coupling by G proteins.

  1990cited by this paper
• Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function.

  1990cited by this paper
• Effects of dopamine on voltage-dependent potassium currents in identified rat lactotroph cells.

  1990cited by this paper
• The GTPase superfamily: a conserved switch for diverse cell functions

  1990cited by this paper
• Guanine nucleotides mediate stimulatory and inhibitory effects on cerebral-cortical membrane phospholipase C activity.

  1989cited by this paper
• Differential Modulation of D1 and D2 Dopamine‐Sensitive Adenylate Cyclases by 17β‐Estradiol in Cultured Striatal Neurons and Anterior Pituitary Cells

  1989cited by this paper
• D-2 dopamine receptor activation reduces free [3H]arachidonate release induced by hypophysiotropic peptides in anterior pituitary cells.

  1989cited by this paper
• Alternative splicing directs the expression of two D2 dopamine receptor isoforms

  1989cited by this paper
• Pertussis toxin treatment in vivo is associated with a decline in G-protein beta-subunits.

  1989cited by this paper
• Structural basis of β‐adrenergic receptor function

  1989cited by this paper
• The dopamine D2 receptor: two molecular forms generated by alternative splicing.

  1989cited by this paper
• Resistance to bromocriptine in prolactinomas.

  1989cited by this paper
• Regulation of GH3-cell function via adenosine A1 receptors. Inhibition of prolactin release, cyclic AMP production and inositol phosphate generation.

  1988cited by this paper
• Cloning and expression of a rat D2 dopamine receptor cDNA

  1988cited by this paper
• Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells.

  1988cited by this paper
• Inhibition of inositol phosphate production is a late, Ca2+-dependent effect of D2 dopaminergic receptor activation in rat lactotroph cells.

  1988cited by this paper
• Angiotensin II increases pituitary cell prolactin release and arachidonate liberation.

  1988cited by this paper
• Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs.

  1988cited by this paper
• Electrophysiological responses to dopamine of rat hypophysial cells in lactotroph‐enriched primary cultures.

  1987cited by this paper
• Dopamine inhibits cytosolic Ca2+ increases in rat lactotroph cells. Evidence of a dual mechanism of action.

  1987cited by this paper
• The D2-dopamine receptor of anterior pituitary is functionally associated with a pertussis toxin-sensitive guanine nucleotide binding protein.

  1987cited by this paper
• An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells.

  1987cited by this paper
• Multiple coupling of neurohormone receptors with cyclic AMP and inositol phosphate production in anterior pituitary cells.

  1987cited by this paper
• Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion.

  1986cited by this paper
• Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine.

  1985cited by this paper
• Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors.

  1984cited by this paper
• Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.

  1983cited by this paper
• Use of a trapped fluorescent indicator to demonstrate effects of thyroliberin and dopamine on cytoplasmic calcium concentrations in bovine anterior pituitary cells

  1983cited by this paper
• Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.

  1982cited by this paper
• Dopamine-inhibited adenylate cyclase in female rat adenohypophysis.

  1981cited by this paper
• Absence of high affinity dopamine receptor in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine.

  1980cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• Bromocriptine treatment of hyperprolactinaemic hypogonadism.

  1978cited by this paper
• Treatment of patients with prolactinomas

  1978cited by this paper
• Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

  1972cited by this paper

• Correlation of pituitary histomorphometry with dopamine and dopamine D2 receptor expression in horses with pituitary pars intermedia dysfunction.

  2022cites this paper
• The Inhibitory Effect of Selected D2 Dopaminergic Receptor Agonists on VEGF-Dependent Neovascularization in Zebrafish Larvae: Potential New Therapy in Ophthalmic Diseases

  2022cites this paper
• RESPONSES OF BOVINE PITUITARY TRANSCRIPTOME PROFILES TO CONSUMPTION OF TOXIC TALL FESCUE AND FORMS OF SELENIUM IN VITAMIN-MINERAL MIXES

  2019cites this paper
• Prolactinomas in males: any differences?

  2019cites this paper
• Polimorfismos del receptor D2

  2017cites this paper
• The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study

  2017cites this paper
• Polymorphic variants in the dopamine receptor D2 in women with endometriosis-related infertility.

  2015cites this paper
• Dopamine receptor D2 genotype (3438) is associated with moderate/severe endometriosis in infertile women in Brazil.

  2013cites this paper
• Prolactin and the physiological regulation of its secretion. A review.

  2013cites this paper
• Bromocriptine: Past And Present : From The In Vitro And In Vivo Experimental Studies To The Clinical Data

  2013cites this paper
• The stimulatory effect of salsolinol on prolactin gene expression within the anterior pituitary of lactating sheep: In vivo and in vitro study

  2012cites this paper
• Structure and Function of Smooth Muscle with Special Reference to Mast Cells

  2012cites this paper
• Giant prolactinoma and effectiveness of medical management.

  2010cites this paper
• Medical therapy of pituitary adenomas: Effects on tumor shrinkage

  2009cites this paper
• Modulation of Voltage-Gated N-Type Calcium Channels by G Protein-Coupled Receptors Involves Lipids and Proteins: A Dissertation

  2008cites this paper
• Direct effects of prolactin and dopamine on the gonadotroph response to GnRH.

  2008cites this paper
• Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men.

  2007cites this paper
• Influence of parasellar extension of macroprolactinomas defined by magnetic resonance imaging on their responsiveness to dopamine agonist therapy

  2006cites this paper
• Advances in the treatment of prolactinomas.

  2006cites this paper
• A case of a prolactinoma resistant to dopamine agonists.

  2005cites this paper
• [Pituitary tumorigenesis].

  2005cites this paper
• The dopamine receptor D2 genotype is associated with hyperprolactinemia.

  2005cites this paper
• [Dopamine-agonist resistant prolactinomas: diagnosis and management].

  2005cites this paper
• Prolactinomas resistentes a agonistas dopaminérgicos: diagnóstico e manejo

  2005cites this paper
• atualização Tumorigênese Hipofisária

  2005cites this paper
• Molecular Basis of Pituitary Oncogenesis

  2004cites this paper
• Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal.

  2002cites this paper
• Signal transduction mechanisms mediating rapid, nongenomic effects of cortisol on prolactin release.

  2002cites this paper
• Dopamine receptor agonists for treating prolactinomas

  2002cites this paper
• Dopamine as a prolactin (PRL) inhibitor.

  2001cites this paper
• Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles (Microtus ochrogaster).

  2000cites this paper
• Neurotransmitters and neurodevelopment. Role of dopamine in neurite outgrowth, target selection and specific synapse formation.

  1998cites this paper
• Multiple Hypothalamic Factors Regulate Pyroglutamyl Peptidase II in Cultures of Adenohypophyseal Cells: Role of the cAMP Pathway

  1998cites this paper
• Dopamine‐D2 Actions on Voltage‐Dependent Calcium Current and Gonadotropin‐II Secretion in Cultured Goldfish Gonadotrophs

  1998cites this paper
• Differential Management of Ca2+ Oscillations by Anterior Pituitary Cells: A Comparative Overview

  1998cites this paper
• Abnormal transduction mechanisms in pituitary adenomas.

  1997cites this paper
• Calcium Signaling Systems

  1997cites this paper
• Inhibitory effects of bromocriptine on vascular smooth muscle cell proliferation.

  1997cites this paper
• Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice.

  1997cites this paper
• Hyperprolactinémies

  1997cites this paper
• Dopamine (D2) receptor regulation of intracellular calcium and membrane capacitance changes in rat melanotrophs.

  1996cites this paper
• Dual regulation of PLA2 and PGI2 production by G proteins in bovine aortic endothelial cells.

  1996cites this paper
• A study of tolerance to apomorphine

  1996cites this paper
• Do dopamine and dopamine receptors have roles in modulating function in the anterior segment?: The evidence

  1995cites this paper
• Psychotic Continuum or Distinct Entities: Perspective from Psychopharmacology

  1995cites this paper
• Direct effects of vitamin D3 analogues on G-protein mediated signalling systems in rat osteosarcoma cells and rat pituitary adenoma cells

  1995cites this paper
• Attempts to pharmacologically modulate prolactin levels and type 1 autoimmune diabetes in the non-obese diabetic (NOD) mouse.

  1995cites this paper
• Prolactin-producing pituitary tumor: resistance to dopamine agonist therapy. Case report.

  1995cites this paper
• Angiotensin II effects on second messengers involved in prolactin secretion are mediated by AT1 receptor in anterior pituitary cells.

  1994cites this paper
• The involvement of dopamine in the regulation of steroidogenesis in rat ovarian cells.

  1994cites this paper